Sensitivity Analysis in Cost-Effectiveness StudiesFrom Guidelines to Practice

被引：0
作者：
Rahul Jain
Michael Grabner
Eberechukwu Onukwugha
机构：
[1] College of Pharmacy,Department of Clinical and Administrative Pharmacy
[2] University of Georgia,Department of Pharmaceutical Health Services Research, School of Pharmacy
[3] University of Maryland,undefined
来源：
PharmacoEconomics | 2011年 / 29卷
关键词：
Sensitivity Analysis; Parameter Uncertainty; Structural Uncertainty; Coverage Decision; Univariate Sensitivity Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cost-effectiveness analysis (CEA) is one of the main tools of economic evaluation. Every CEA is based on a number of assumptions, some of which may not be accurate, introducing uncertainty. Sensitivity analysis (SA) formalizes ways to measure and evaluate this uncertainty. Specific sources of uncertainty in CEA have been noted by various researchers. In this work, we consolidate across all sources of uncertainty, discuss the imbalanced attention to SA across different sources, and discuss criteria for conducting and reporting SA to help bridge the gap between guidelines and practice.
引用
收藏
页码：297 / 314
页数：17
相关论文
共 112 条
  • [1] Weinstein M(1977)Foundations of cost-effectiveness analysis for health and medical practices N Engl J Med 296 716-21
  • [2] Stason W(2009)Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada JAMA 302 1437-43
  • [3] Clement FM(2000)Handling uncertainty in cost-effectiveness models Pharmacoeconomics 17 479-500
  • [4] Harris A(2006)Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment Pharmacoeconomics 24 355-71
  • [5] Li JJ(2009)Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making Health Technol Assess 13 1-61
  • [6] Briggs A(1996)Guidelines for authors and peer reviewers of economic submissions to the BMJ The BMJ Economic Evaluation Working Party 313 275-83
  • [7] Philips Z(1997)User’s guides to medical literature: XIII How to use an article on economic analysis of clinical practice: A 277 1552-7
  • [8] Bojke L(1999)Towards a European consensus on conducting and reporting health economic evaluations: a report from the ISPOR Inaugural European Conference Value Health 2 281-7
  • [9] Sculpher M(2000)Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application Pharmacoeconomics 17 461-77
  • [10] Andronis L(2002)Health economic evaluations using decision analytic modeling: principles and practices Utilization of a checklist to their development and appraisal 18 94-111
12345678910